- Home
- CRDF vs PSF Comparison
CRDF vs PSF Comparison
Compare CRDF & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- PSF
- Stock Information
- Founded
- CRDF 1999
- PSF 2010
- Country
- CRDF United States
- PSF United States
- Employees
- CRDF N/A
- PSF N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- PSF Investment Managers
- Sector
- CRDF Health Care
- PSF Finance
- Exchange
- CRDF Nasdaq
- PSF Nasdaq
- Market Cap
- CRDF 233.5M
- PSF 236.8M
- IPO Year
- CRDF N/A
- PSF N/A
- Fundamental
- Price
- CRDF $2.64
- PSF $20.53
- Analyst Decision
- CRDF Strong Buy
- PSF
- Analyst Count
- CRDF 6
- PSF 0
- Target Price
- CRDF $11.92
- PSF N/A
- AVG Volume (30 Days)
- CRDF 3.0M
- PSF 25.0K
- Earning Date
- CRDF 07-29-2025
- PSF 01-01-0001
- Dividend Yield
- CRDF N/A
- PSF 7.69%
- EPS Growth
- CRDF N/A
- PSF N/A
- EPS
- CRDF N/A
- PSF N/A
- Revenue
- CRDF $545,000.00
- PSF N/A
- Revenue This Year
- CRDF N/A
- PSF N/A
- Revenue Next Year
- CRDF N/A
- PSF N/A
- P/E Ratio
- CRDF N/A
- PSF N/A
- Revenue Growth
- CRDF N/A
- PSF N/A
- 52 Week Low
- CRDF $2.01
- PSF $16.00
- 52 Week High
- CRDF $5.64
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- CRDF 34.68
- PSF 67.03
- Support Level
- CRDF $2.31
- PSF $20.42
- Resistance Level
- CRDF $4.52
- PSF $20.61
- Average True Range (ATR)
- CRDF 0.37
- PSF 0.11
- MACD
- CRDF -0.21
- PSF 0.02
- Stochastic Oscillator
- CRDF 14.67
- PSF 86.44
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.